The translatome of glioblastoma
Glioblastoma (GB), the most common and aggressive brain tumor, demonstrates intrinsic resistance to current therapies, resulting in poor clinical outcomes. Cancer progression can be partially attributed to the deregulation of protein translation mechanisms that drive cancer cell growth. In this stud...
Saved in:
| Main Authors: | Fleur M. G. Cornelissen, Zhaoren He, Edward Ciputra, Richard R. deHaas, Ammarina Beumer‐Chuwonpad, David Noske, W. Peter Vandertop, Sander R. Piersma, Connie R. Jiménez, Cornelis Murre, Bart A. Westerman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.13743 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ribosome profiling reveals differences in global translational vs transcriptional gene expression changes during early Candida albicans biofilm formation
by: Vasanthakrishna Mundodi, et al.
Published: (2025-03-01) -
Moesin silencing enhances the radiosensitivity of glioblastoma by inhibiting DNA damage repair via CD44/AKT1 signaling pathway
by: Xin Ding, et al.
Published: (2025-07-01) -
Deciphering Radiotherapy Resistance: A Proteomic Perspective
by: Davide Perico, et al.
Published: (2025-06-01) -
PHGDH activation fuels glioblastoma progression and radioresistance via serine synthesis pathway
by: Xiaojin Liu, et al.
Published: (2025-03-01) -
Striatal cell-type–specific molecular signatures reveal potential therapeutic targets in a model of dystonia
by: Kaitlyn M. Roman, et al.
Published: (2025-08-01)